These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 21369712)
81. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology. Bachhav YG; Heinrich A; Kalia YN Eur J Pharm Biopharm; 2013 Jun; 84(2):355-64. PubMed ID: 23207321 [TBL] [Abstract][Full Text] [Related]
82. Enhancement of the transdermal delivery of zidovudine by pretreating the skin with two physical enhancers: microneedles and sonophoresis. Martínez-Segoviano IJ; Ganem-Rondero A Daru; 2021 Dec; 29(2):279-290. PubMed ID: 34216369 [TBL] [Abstract][Full Text] [Related]
83. Research progress of physical transdermal enhancement techniques in tumor therapy. Han W; Liu F; Liu G; Li H; Xu Y; Sun S Chem Commun (Camb); 2023 Mar; 59(23):3339-3359. PubMed ID: 36815500 [TBL] [Abstract][Full Text] [Related]
84. Transdermal Delivery of Baclofen Using Iontophoresis and Microneedles. Junaid MSA; Banga AK AAPS PharmSciTech; 2022 Mar; 23(3):84. PubMed ID: 35288825 [TBL] [Abstract][Full Text] [Related]
85. Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications. Yu YQ; Yang X; Wu XF; Fan YB Front Bioeng Biotechnol; 2021; 9():646554. PubMed ID: 33855015 [TBL] [Abstract][Full Text] [Related]
86. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin. Nolan LM; Corish J; Corrigan OI; Fitzpatrick D Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130 [TBL] [Abstract][Full Text] [Related]
87. [Augmentation of transdermal drug penetration]. Préat MV Bull Mem Acad R Med Belg; 1998; 153(5-6):295-300; discussion 301-2. PubMed ID: 9988935 [TBL] [Abstract][Full Text] [Related]
88. Drug delivery routes in skin: a novel approach. Barry BW Adv Drug Deliv Rev; 2002 Nov; 54 Suppl 1():S31-40. PubMed ID: 12460714 [TBL] [Abstract][Full Text] [Related]
89. Transdermal delivery of cyclosporin-A using electroporation. Wang S; Kara M; Krishnan TR J Control Release; 1998 Jan; 50(1-3):61-70. PubMed ID: 9685873 [TBL] [Abstract][Full Text] [Related]
90. Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach. Denet AR; Ucakar B; Préat V Pharm Res; 2003 Dec; 20(12):1946-51. PubMed ID: 14725358 [TBL] [Abstract][Full Text] [Related]
91. Microneedles: a valuable physical enhancer to increase transdermal drug delivery. Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Molina-Trinidad E; Casas-Alancaster N; Revilla-Vázquez AL J Clin Pharmacol; 2011 Jul; 51(7):964-77. PubMed ID: 21148047 [TBL] [Abstract][Full Text] [Related]
92. Perspectives on transdermal ultrasound mediated drug delivery. Smith NB Int J Nanomedicine; 2007; 2(4):585-94. PubMed ID: 18203426 [TBL] [Abstract][Full Text] [Related]
93. Potential of peptide-based enhancers for transdermal delivery. Lopes LB; Carvalho VF; de Lemos DP Curr Pharm Des; 2015; 21(20):2814-22. PubMed ID: 25925116 [TBL] [Abstract][Full Text] [Related]
94. Transdermal delivery of vancomycin hydrochloride: Influence of chemical and physical permeation enhancers. Datta D; Panchal DS; Venuganti VVK Int J Pharm; 2021 Jun; 602():120663. PubMed ID: 33933644 [TBL] [Abstract][Full Text] [Related]
98. Microporation applications for enhancing drug delivery. Banga AK Expert Opin Drug Deliv; 2009 Apr; 6(4):343-54. PubMed ID: 19348604 [TBL] [Abstract][Full Text] [Related]
99. Effective use of transdermal drug delivery in children. Delgado-Charro MB; Guy RH Adv Drug Deliv Rev; 2014 Jun; 73():63-82. PubMed ID: 24333231 [TBL] [Abstract][Full Text] [Related]
100. Transdermal delivery of timolol by electroporation through human skin. Denet AR; Préat V J Control Release; 2003 Mar; 88(2):253-62. PubMed ID: 12628332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]